Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Viotra versus amitriptyline in SSRI-resistant major depressive disorder
2013-000719-26Phase 2Completed
- Sponsor
- e-therapeutics plc
- Start
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, double-blind trial of diclofenac + paracetamol in major depressive disorder (MDD) (2 arms), sponsored by e-therapeutics plc. Primary endpoint: Baseline-adjusted MADRS score at week 8. Started Apr 2013; status: completed.
02
Drugs
diclofenac + paracetamol
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2013-000719-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000719-26.